Evolutionary Indicators of Human Immunodeficiency Virus Type 1 Reservoirs and Compartments
Open Access
- 1 May 2003
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (9), 5540-5546
- https://doi.org/10.1128/jvi.77.9.5540-5546.2003
Abstract
In vivo virologic compartments are cell types or tissues between which there is a restriction of virus flow, while virologic reservoirs are cell types or tissues in which there is a relative restriction of replication. The distinction between reservoirs and compartments is important because therapies that would be effective against a reservoir may not be effective against viruses produced by a given compartment, and vice versa. For example, the use of cytokines to “flush out” long-lived infected cells in patients on highly active antiretroviral therapy (T. W. Chun, D. Engel, M. M. Berrey, T. Shea, L. Corey, and A. S. Fauci, Proc. Natl. Acad. Sci. USA 95:8869-8873, 1998) may be successful for a latent reservoir but may not impact a compartment in which virus continues to replicate because of poor drug penetration. Here, we suggest phylogenetic criteria to illustrate, define, and differentiate between reservoirs and compartments. We then apply these criteria to the analysis of simulated and actual human immunodeficiency virus type 1 sequence data sets. We report that existing statistical methods work quite well at detecting viral compartments, and we learn from simulations that viral divergence from a calculated most recent common ancestor is a strong predictor of viral reservoirs.Keywords
This publication has 29 references indexed in Scilit:
- Persistence of Wild-Type Virus and Lack of Temporal Structure in the Latent Reservoir for Human Immunodeficiency Virus Type 1 in Pediatric Patients with Extensive Antiretroviral ExposureJournal of Virology, 2002
- The Challenge of Viral Reservoirs in HIV-1 InfectionAnnual Review of Medicine, 2002
- A COMPARATIVE STUDY OF ASYMMETRIC MIGRATION EVENTS ACROSS A MARINE BIOGEOGRAPHIC BOUNDARYEvolution, 2001
- Human Immunodeficiency Virus Type 1 Quasi Species That Rebound after Discontinuation of Highly Active Antiretroviral Therapy Are Similar to the Viral Quasi Species Present before Initiation of TherapyThe Journal of Infectious Diseases, 2001
- Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapyJournal of Clinical Investigation, 2000
- Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral TherapyNew England Journal of Medicine, 1999
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- Quantitation of HIV-1 RNA in Plasma Predicts Outcome after SeroconversionAnnals of Internal Medicine, 1995
- V3 Sequences of Paired HIV-1 Isolates from Blood and Cerebrospinal Fluid Cluster According to Host and Show Variation Related to the Clinical Stage of DiseaseVirology, 1993